Skip to main content
. 2021 Mar 9;11:605606. doi: 10.3389/fonc.2021.605606

Figure 3.

Figure 3

Role of different lncRNA in testicular cancer pathogenesis. Testicular cancer cells proliferation is promoted by lncRNA HOTTIP and SPRY4-IT1, while it is inhibited by NCL1-C, which also drives testicular cancer cells apoptosis. Cisplatin-based treatments resistance can be promoted by the H19/TDRG1 pathway, since H19 is able to upregulate TDRG1, which in turn triggers therapy resistance. Finally, testicular tumor invasiveness is promoted by SPRY4-IT1, which not only increases the cell proliferative rate, but also their motility and invasiveness.